| 金龙胶囊联合FOLFOX4方案治疗晚期胃癌的疗效分析 |
| |
| 引用本文： | 李鹏,周彤,凌杨. 金龙胶囊联合FOLFOX4方案治疗晚期胃癌的疗效分析[J]. 中外医疗, 2012, 31(1): 1-2 |
| |
| 作者姓名： | 李鹏 周彤 凌杨 |
| |
| 作者单位： | 苏州大学附属常州肿瘤医院,江苏常州,213000 |
| |
| 摘 要： | 目的探讨金龙胶囊联合FOLFOX4方案治疗晚期胃癌的临床疗效。方法将我院2005年12月至2009年12月收治的60例局部晚期胃癌患者随机分为A、B2组,A组采用FOLFOX4新辅助化疗方案,B组在A组的基础上口服金龙胶囊治疗,比较2组患者的临床疗效,不良反应和生活质量。结果 B组临床疗效的总有效率为56.7%,A组为63.3%,2组无显著性差异,P〉0.05。但B组的PD率显著低于A组,P〈0.05。且B组的不良反应和生活质量要显著优于A组,P〈0.05。结论金龙胶囊联合FOLFOX4方案治疗晚期胃癌疗效较好,可减轻化疗的毒副反应。
|
| 关 键 词： | 晚期胃癌 新辅助化疗 疗效 不良反应 |
The Efficacy Analysis of Golden Dragon Capsule FOLFOX 4 Regimen in Advanced Gastric Cancer |
| |
| Affiliation: | Gastric Cancer |
| |
| Abstract: | Objective To discuss clinical of Golden dragon capsule FOLFOX4 regimen in advanced gastric cancer.Methods Choose the 60 cases of Patients with locally advanced gastric cancer in our hospital during 2005.12 to 2009.12.They were randomly divided into two groups A and B,Neoadjuvant chemotherapy using FOLFOX4 of group A,Group A Group B on the basis of oral Golden Dragon Capsule,The clinical efficacy of two groups were compared,Adverse reactions and quality of Iife.Results the group B clinical total effective rate was 56.70 ,the Group A was 63.30 ,There was no significant difference,P
|
| |
| Keywords: | Advanced gastric cancer Neoadjuvant chemotherapy Effect Adverse reactions |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
